Mission Possible
Imagine a World where autoimmune is history
About Us
Finding Inspiration in Every Health Obstacle
NostraBiome was founded by Calin Popescu, a serial entrepreneur and inventor after he spent over 10 years suffering from IBD that did not respond to traditional medications. Frustrated with the lack of options, Mr. Popescu applied his expertise in technology to develop a personalized approach to understanding and treating the disease.
Our Story
After extensive testing and analysis, Mr. Popescu discovered correlations and patterns in the disease that allowed him to attack specific elements and gradually improve his symptoms. He realized that IBD requires a personalized approach, tailored to the unique factors that influence the disease in each individual.
We believe that precision and personalized medicine are the key to solving the complex puzzle of IBD. Using groundbreaking innovations in computer vision and artificial intelligence, we aim to hack and break the inflammatory code of each individual and recommend chronological steps to reverse the symptoms of the disease.
Our mission is to offer hope and improved quality of life to the over 6 million people worldwide who suffer from IBD and a few other millions suffering from autoimmune and chronic conditions. While we understand that not all individuals will benefit from our approach, we are dedicated to using technology and medical expertise to make a difference in the lives of those who do.
Our Thesis
Traditional mass medical approaches have failed to address the complexity of IBD and most of chronic conditions. We know that a personalized and advanced technological approach is necessary to address the multitude of factors that trigger an autoimmune disease.
We reject the notion that IBD is an untreatable immune response. Instead, we understand it as a normal response to a variety of causes that are not fully understood.
​
Our cutting-edge technology uses artificial intelligence to understand the unique way it affects each individual.
By identifying the factors that trigger IBD, we provide precision recommendations to break the vicious circle of the disease.
We have successfully treated IBD for a few individuals with significant investment. Now, we are committed to making our approach affordable and accessible to everyone suffering from IBD.